Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, fell short of expectations in a late-stage clinical trial ...

More appealing than its wide range of offerings is that ClassPass offers a free one-month trial. If you're in it for the freebies, or can't decide if you want to commit or not, ClassPass allows ...

Netlify/Decap CMS alternative. Fast, lightweight, Git-based headless CMS. Modern UX, first-class i18n support among hundreds of improvements. Open source & free. Made with Svelte.

Live stream Lehecka vs. Dimitrov in the 2025 Brisbane International online for free from anywhere in the world.

If you're just starting to invest, many top brokerages offer free stock-trading platforms that can get you started. They offer zero-commission trading and no account minimums, making investing ...

Digital Spy has got all the answers you need and more – so here is everything you should know about Crunchyroll membership, from the free trial to subscription options. If you've signed up for a ...

s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals. The stock (NMRA) was on track for ...

The U.S.-based trial of 383 adult patients failed to hit the primary endpoint, as navacaprant didn’t lead to a statistically significant reduction in depressive symptoms, measured by the six ...

BioVie Inc. executives should have disclosed protocol compliance problems affecting its clinical trial for its Alzheimer’s drug, instead they exposed the pharmaceutical company to financial harm and a ...